PTN Palatin Technologies Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: PTN

Price (delayed)

$1.71

Market cap

$27.59M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.61

Enterprise value

$18.93M

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop ...

Highlights
PTN's gross profit has surged by 164% year-on-year and by 18% since the previous quarter
The revenue has surged by 146% year-on-year and by 17% since the previous quarter
The company's quick ratio has surged by 108% QoQ but it has shrunk by 56% YoY
The company's EPS fell by 45% QoQ but it rose by 4.7% YoY
PTN's equity has dropped by 170% year-on-year and by 133% since the previous quarter
The net income has plunged by 50% from the previous quarter and by 22% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.palatin.com
Peers: MNOV NBIX GLYC ANIP

Key stats

What are the main financial stats of PTN
Market
Shares outstanding
16.14M
Market cap
$27.59M
Enterprise value
$18.93M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.67
Earnings
Revenue
$7.1M
EBIT
-$31.58M
EBITDA
-$31.25M
Free cash flow
-$27.6M
Per share
EPS
-$2.61
Free cash flow per share
-$1.96
Book value per share
-$0.83
Revenue per share
$0.5
TBVPS
$0.96
Balance sheet
Total assets
$13.55M
Total liabilities
$24.52M
Debt
$821,374
Equity
-$11.38M
Working capital
$1.05M
Liquidity
Debt to equity
-0.07
Current ratio
1.09
Quick ratio
1.06
Net debt/EBITDA
0.28
Margins
EBITDA margin
-440.2%
Gross margin
95.3%
Net margin
-445.1%
Operating margin
-324.8%
Efficiency
Return on assets
-184.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-1,340.7%
Return on sales
-444.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PTN stock price

How has the Palatin Technologies stock price performed over time
Intraday
-0.58%
1 week
-7.07%
1 month
5.56%
1 year
-27.54%
YTD
-57.04%
QTD
-8.56%

Financial performance

How have Palatin Technologies's revenue and profit performed over time
Revenue
$7.1M
Gross profit
$6.77M
Operating income
-$23.06M
Net income
-$31.59M
Gross margin
95.3%
Net margin
-445.1%
PTN's gross profit has surged by 164% year-on-year and by 18% since the previous quarter
The revenue has surged by 146% year-on-year and by 17% since the previous quarter
The company's operating margin has surged by 73% YoY and by 34% QoQ
Palatin Technologies's net margin has soared by 51% YoY but it has decreased by 29% from the previous quarter

Growth

What is Palatin Technologies's growth rate over time

Valuation

What is Palatin Technologies stock price valuation
P/E
N/A
P/B
N/A
P/S
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.67
The company's EPS fell by 45% QoQ but it rose by 4.7% YoY
PTN's equity has dropped by 170% year-on-year and by 133% since the previous quarter
The revenue has surged by 146% year-on-year and by 17% since the previous quarter
The stock's price to sales (P/S) is 42% less than its last 4 quarters average of 5.9

Efficiency

How efficient is Palatin Technologies business performance
PTN's return on assets has dropped by 149% year-on-year and by 91% since the previous quarter
The company's return on sales has surged by 58% YoY but it fell by 5% QoQ

Dividends

What is PTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PTN.

Financial health

How did Palatin Technologies financials performed over time
The total assets is 45% smaller than the total liabilities
The company's quick ratio has surged by 108% QoQ but it has shrunk by 56% YoY
The current ratio has plunged by 59% YoY but it has soared by 51% from the previous quarter
Palatin Technologies's debt is 107% more than its equity
PTN's equity has dropped by 170% year-on-year and by 133% since the previous quarter
Palatin Technologies's debt to equity has surged by 63% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.